跳至主要内容
临床试验/NCT00387829
NCT00387829终止不适用

Randomized Controlled Trial of DuraGen Plus® Adhesion Barrier Matrix to Minimize Adhesions Following Lumbar Discectomy

Integra LifeSciences Corporation72 个研究点 分布在 1 个国家目标入组 347 人开始时间: 2006年10月最近更新:
适应症

试验速览

阶段
不适用
状态
终止
入组人数
347
试验地点
72
主要终点
Radiological, Pain, and Functional Outcome Assessments

研究概览

简要总结

To evaluate the safety and effectiveness of DuraGen Plus® Adhesion Barrier Matrix as an adhesion barrier in spinal surgery to reduce the extent of peridural fibrosis formation and radicular pain in comparison to a control group receiving standard care.

详细描述

For more information, please visit www.DuragenStudy.com

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double (Participant, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 70 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • 未提供

排除标准

  • 未提供

结局指标

主要结局

Radiological, Pain, and Functional Outcome Assessments

时间窗: 6 months

Radiological score (MRI Outcome score): MRI peridural fibrosis in 5 consecutive 2-D axial Spin Echo T1 axial slices. Score consists of the ratio of total available space in each image and the amount of scar identified (percentage). Pain (VAS): Visual Analog Score used to rate the subject's pain.VAS scale is a 100 mm horizontal line, where the far left side of the scale equals (0) no pain and the far right side of the scale (100) equals the worst possible pain. Functional outcome score (ODI): Used to assess the effect leg or back pain on everyday life. Questions relate to areas such as walking, lifting, sitting, ability to travel as well as other common activities. Ten questions with scores from 0-5. Calculated as percentage: (Actual score /Maximum overall score (worst disability))\*100.

次要结局

  • Radiological, Pain, and Functional Outcome Assessments(12 months)

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (72)

Loading locations...

相似试验